about
T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea.Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice modelThe Early Expression of HLA-DR and CD64 Myeloid Markers Is Specifically Compartmentalized in the Blood and Lungs of Patients with Septic Shock.Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component.Monitoring of procalcitonin but not interleukin-6 is useful for the early prediction of anastomotic leakage after colorectal surgery.Effect of granulocyte colony-stimulating factor on circulating immune and stem cells in septic shock: revisit the basics and consider giving it another chance.Three-dimensional printed polycaprolactone-based scaffolds provide an advantageous environment for osteogenic differentiation of human adipose-derived stem cells.Sepsis modulates the human hematopoietic stem cell compartment in peripheral blood and bone marrowMobilization of Stem and Progenitor Cells in Septic Shock PatientsImmunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response.Fas-positive lymphocytes are associated with systemic inflammation in obstructive sleep apnea syndrome.Procalcitonin in early onset ventilator-associated pneumoniaBronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?Sepsis therapies: learning from 30 years of failure of translational research to propose new leadsCurrent gaps in sepsis immunology: new opportunities for translational researchThe Fluctuations of Leukocytes and Circulating Cytokines in Septic Humanized Mice Vary With OutcomeInner sensors of endotoxin - implications for sepsis research and therapy
P50
Q35691513-7145B739-EE2E-4EED-A245-23229D9B39C0Q35954071-A0D26296-0B84-4175-9251-B2589EE8C5D1Q37060070-29A01F89-F32E-425D-911C-76E96FF005AAQ39856003-02BD6B68-A03B-4B43-96A0-6CC8F76D46A5Q40418596-F1C76EA3-F7EB-4B53-9624-48A3D446DA90Q44040437-B5E97BC9-496E-4E4B-8696-D772E71235FCQ51171415-5207FDFF-3652-469B-B2D8-B87BF9A950A8Q59399150-F2F79721-D420-4FA8-83D2-3F0BC8774152Q64084427-02B1DE35-BB2E-44FD-91C6-F1D11FBBBC58Q64916418-0969DD34-F9E9-4938-910F-6967F9B0D812Q64994826-2C0B3B91-B5F0-4BB5-B362-D599882CCF8AQ84059276-180DCE1B-BD6C-4D25-9D6E-2F3B2C2006FFQ84866213-38C1284A-3376-45E8-9BFD-6DBAB4400105Q90354681-CC196FAF-2171-42BE-A4B7-731A9DF77B03Q90828848-F4BB87DA-DFEE-44F8-927A-46AD17AD02A3Q91811477-1E5DB75B-77A9-4519-B325-BF41F06F2DB3Q92189965-2A626922-A0FE-45E6-A884-326778E9F00F
P50
description
investigador
@es
researcher
@en
name
Tomasz Skirecki
@en
type
label
Tomasz Skirecki
@en
prefLabel
Tomasz Skirecki
@en
P31
P496
0000-0001-6233-7758